ALL KEYWORDSRadiofrequency Ablation (RFA) of Breast CancerRelated SpecialistsShowing 3 of 7Igor LatichMDJeffrey PollakMDFrancis LeeMD, PhD, MBAMore Related SpecialistsRelated Fact SheetsRadiofrequency Ablation (RFA)Related Clinical TrialsA First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, As a Single Agent in Advanced Solid Tumor Patients and in Combination with Fulvestrant in Patients with Advanced Breast CancerBreast CancerRelated NewsResearch & InnovationResearch & InnovationRelated DepartmentsShowing 3 of 59Internal MedicineTherapeutic RadiologyHead & Neck RadiotherapyMore Related Departments
